insights_auto
Why is BOT up 5,56%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
0,019 A$
arrow_upward
+5,56%(+0,0010) 1D
1 հոկ, 16:10:19 GMT+10 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
0,02 A$
High
0,02 A$
Low
0,02 A$
Mkt. cap
47,22 մլն
Avg. vol.
5,84 մլն
Volume
15,48 մլն
52-wk high
0,17 A$
52-wk low
0,02 A$
EPS
-0,03 A$
Shares outstanding
2,76 մլրդ
No. of employees
11
Open
0,02 A$
High
0,02 A$
Low
0,02 A$
Mkt. cap
47,22 մլն
Avg. vol.
5,84 մլն
Volume
15,48 մլն
52-wk high
0,17 A$
52-wk low
0,02 A$
EPS
-0,03 A$
Shares outstanding
2,76 մլրդ
No. of employees
11
News stories
From web sources and news partners
The Globe and Mail
·
27 րոպե առաջ
Kaplan Fox Continues to Alert Investors of AST SpaceMobile, Inc. (NASDAQ: ASTS) to a Class Action Deadline on November 13, 2026
Nasdaq
·
16 րոպե առաջ
A Quarter of Companies Have No Analyst Coverage
Investing.com
·
1 ժամ առաջ
Twilio to join S&P 500 as S&P Dow Jones reshuffles indices
Investor's Business Daily
·
2 ժամ առաջ
Dow Jones Futures: Stocks Rise Off Support As Yields Tumble, Micron, Meta In Focus; Tesla, Jobs Report Due
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd